Anandi Krishnan

Dr. Anandi Krishnan, Ph.D. is an associate professor in the Department of Biomedical Engineering and a faculty member with the graduate programs in Molecular Biosciences and Computer Science. She is also an affiliate faculty of the Rutgers Cancer Institute of New Jersey, the NJ Alliance for Clinical and Translational Science and the Robert Wood Johnson School of Medicine. For over a decade prior to joining Rutgers, Dr. Krishnan was an integral member of the Stanford University School of Medicine serving in roles of both academic research and administration. Dr. Krishnan completed her PhD in Bioengineering at Penn State University and postdoctoral training in clinical and translational research at Duke University.

Dr. Krishnan’s Plateletome lab focuses on integrating multi-omic discovery with molecular, cellular, and in vivo approaches to better understand blood platelet responses in health and disease, thus expanding beyond their classical function in hemostasis and thrombosis. This cross-disciplinary research holds significance in a broad spectrum of chronic age-related disorders, from cancer, inflammation, and neurodegeneration. Projects are also highly collaborative across institutions, and support scientists from diverse backgrounds. Funding for Dr. Krishnan’s research includes NIH NHGRI clinical scientist career development award, HTRS Mid-Career Research Award, MPN Research Foundation Challenge grant, Stanford and Rutgers internal awards and NIH NCATS diversity/research re-entry award.

Hematology, Thrombosis, Genomic Medicine, Systems Biology, Platelets and Megakaryocytes, Biointerfaces, Biomaterials, Translational Medicine

Integrating genome-scale technologies, systematic high-throughput analyses, and deep biological interpretation toward developing scalable and robust molecular assays for prevention, early detection, and intervention in diverse disease settings. A particular focus is on blood platelets and their expanding roles in chronic age-related disorders such as cancer, inflammation, and neurodegeneration.

• Nominated Member, Minority Recruitment Initiative, American Society of Hematology (2022-26)
• Team Science Leadership Program at Stanford Medicine (2022)
• Inaugural Planning Committee Member for workshop on Students Exploring Academic Research Careers in Hematology (SEARCH), Hemostasis & Thrombosis Research Society (2023)
• Host Mentor, Training Fellowship, International Society for Thrombosis and Haemostasis (2023)
• Invited Panelist (mentoring), Gordon Research Conferences on Megakaryocytes and Platelets (2023)
• Featured twice by NIH in ‘Features & Briefs’ & ‘Diversity Awardee Profiles’ at NCATS website (2017,18)
• Founding Member and Seed Grants Reviewer, Stanford Predictives and Diagnostics Accelerator (2013-16)
• Postdoctoral Fellowship, American Stroke Association-Henrietta & Frederick H. Bugher Foundation (2008-11)
• Thrombosis & Hemostasis Societies of North America (THSNA) Young Investigator Award (2020)
• American Vacuum Society Outstanding Scholarship in Doctoral Research Award (2005)
• Johnson & Johnson Ethicon Focused Giving Award for Graduate Research (2002)

• 2024-present Visiting Scholar, Stanford University
• 2022-present Member, Biomedical Engineering Society
• 2022-present Member, Hemostasis & Thrombosis Research Society
• 2021-present Member, International Society for Thrombosis and Haemostasis
• 2016-present Member, American Society of Hematology
• 2019-present Member, International Society for Experimental Hematology

• Postdoctoral, Duke University, Neurology and Duke Translational Research Institute (2011)
• Clinical Research Training, Duke University, Duke Clinical Research Institute (2011)
• Postdoctoral, Penn State University, Penn State Heart and Vascular Institute (2008)
• Ph.D., Penn State University, Bioengineering (2005)
• B. Tech, Kerala University, Engineering (2000)